(Q35673808)

9 August 2017

1 reference

title

New developments in antibacterial choice for lower respiratory tract infections in elderly patients (English)

1 reference

9 August 2017

Anna Maria Ferrara

1

1 reference

9 August 2017

Anna Maria Fietta

series ordinal

2

1 reference

9 August 2017

publication date

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

volume

21

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

167-186

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200421030-00003

9 August 2017

exact match

0 references

cites work

Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.

1 reference

12 December 2020

Etiology of severe pneumonia in the very elderly

1 reference

12 December 2020

Antibiotic use in the elderly: issues and nonissues

1 reference

12 December 2020

Lower respiratory tract infection and pneumonia in the community.

1 reference

12 December 2020

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

1 reference

12 December 2020

Community-acquired pneumonia

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: Spanish multicentre study.

1 reference

12 December 2020

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

1 reference

12 December 2020

Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus in Europe

1 reference

12 December 2020

Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae

1 reference

12 December 2020

The fluoroquinolone antibacterials: past, present and future perspectives

1 reference

12 December 2020

Oxazolidinone antibiotics.

1 reference

12 December 2020

Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments

1 reference

12 December 2020

Community-acquired pneumonia: new guidelines for management.

1 reference

12 December 2020

[Pharmacokinetics in the elderly]

1 reference

12 December 2020

Clinical aspects and prognostic factors in elderly patients hospitalised for community-acquired pneumonia

1 reference

12 December 2020

Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study

1 reference

12 December 2020

Surveillance for outbreaks of respiratory tract infections in nursing homes

1 reference

12 December 2020

Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

1 reference

12 December 2020

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

1 reference

12 December 2020

Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin

1 reference

12 December 2020

QT interval prolongation and torsades de pointes due to erythromycin lactobionate

1 reference

12 December 2020

Guidelines for the treatment of acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Once-daily dosing of aminoglycosides: how much monitoring is truly required?

1 reference

12 December 2020

Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease

1 reference

12 December 2020

The use of intramuscular cefoperazone versus intramuscular ceftriaxone in patients with nursing home-acquired pneumonia

1 reference

12 December 2020

Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens

1 reference

12 December 2020

Characteristics of French methicillin-resistant Staphylococcus aureus isolates with decreased susceptibility or resistance to glycopeptides

1 reference

12 December 2020

Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

1 reference

12 December 2020

Microbiology of Severe Aspiration Pneumonia in Institutionalized Elderly

1 reference

12 December 2020

Pharmacodynamics of antimicrobial agents and rationale for their dosing.

1 reference

12 December 2020

New uses for new and old quinolones and the challenge of resistance

1 reference

12 December 2020

1 reference

12 December 2020

Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review

1 reference

12 December 2020

Nosocomial pneumonia: emerging concepts in diagnosis, management, and prophylaxis

1 reference

12 December 2020

The chronic obstructive pulmonary disease exacerbation

1 reference

12 December 2020

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

12 December 2020

Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy.

1 reference

12 December 2020

Influence of Pharmacokinetic and Pharmacodynamic Principles on Antibiotic Selection

1 reference

12 December 2020

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus (MRSA) in the community: who's watching?

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of fluoroquinolones

1 reference

12 December 2020

The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

1 reference

12 December 2020

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

12 December 2020

The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections

1 reference

12 December 2020

The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications

1 reference

12 December 2020

Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media

1 reference

12 December 2020

Worldwide guidelines for respiratory tract infections: community-acquired pneumonia

1 reference

12 December 2020

Clinical use of the fluoroquinolones

1 reference

12 December 2020

Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy

1 reference

12 December 2020

Community-acquired pneumonia in older people: the need for a broader perspective

1 reference

12 December 2020

Quality of care, process, and outcomes in elderly patients with pneumonia

1 reference

12 December 2020

Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995

1 reference

12 December 2020

Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections

1 reference

12 December 2020

Therapy of ventilator-associated pneumonia: the Tarragona Strategy

1 reference

12 December 2020

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

1 reference

12 December 2020

Impact of Gram-positive resistance on outcome of nosocomial pneumonia

1 reference

12 December 2020

Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection

1 reference

12 December 2020

Pneumonia in the elderly: overview of diagnostic and therapeutic approaches

1 reference

12 December 2020

The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease

1 reference

12 December 2020

A perspective on cellular immunity in the elderly

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin

1 reference

12 December 2020

Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae

1 reference

12 December 2020

Pneumonia in the elderly

1 reference

12 December 2020

1 reference

12 December 2020

Aspiration pneumonia and dysphagia in the elderly

1 reference

12 December 2020

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

12 December 2020

Outpatient parenteral treatment of bacterial infections: the Italian model as an international trend?

1 reference

12 December 2020

The aging immune system: primer and prospectus

1 reference

12 December 2020

Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

1 reference

12 December 2020

Linezolid: pharmacokinetic characteristics and clinical studies.

1 reference

12 December 2020

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors

1 reference

12 December 2020

Severe but reversible encephalopathy associated with cefepime

1 reference

12 December 2020

Community-acquired pneumonia: the evolving challenge

1 reference

12 December 2020

Epidemiology and unique aspects of aging and infectious diseases

1 reference

12 December 2020

1 reference

12 December 2020

The therapeutic monitoring of antimicrobial agents

1 reference

12 December 2020

Linezolid--a review of the first oxazolidinone

1 reference

12 December 2020

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers

1 reference

12 December 2020

Predicting antibacterial response from pharmacodynamic and pharmacokinetic profiles

1 reference

12 December 2020

Serotype 19f multiresistant pneumococcal clone harboring two erythromycin resistance determinants (erm(B) and mef(A)) in South Africa

1 reference

12 December 2020

Pneumonia in the elderly

1 reference

12 December 2020

Nursing home-acquired pneumonia

1 reference

12 December 2020

Hospital-acquired pneumonia: epidemiology, etiology, and treatment

1 reference

12 December 2020

beta-Lactamases in laboratory and clinical resistance

1 reference

12 December 2020

More on fluoroquinolone antibiotics and tendon rupture.

1 reference

12 December 2020

Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients

1 reference

12 December 2020

Application of fluoroquinolone pharmacodynamics

1 reference

12 December 2020

Streamlining antimicrobial therapy for lower respiratory tract infections

1 reference

12 December 2020

Community-acquired pneumonia guidelines--an international comparison: a view from Europe.

1 reference

12 December 2020

Update on community-acquired pneumonia: impact of antibiotic resistance on clinical outcomes

1 reference

12 December 2020

Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin for the treatment of patients with nosocomial lower respiratory tract infection. Piperacillin/tazobactam Nosocomial Pneumonia Study Group.

1 reference

12 December 2020

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

1 reference

12 December 2020

Nutritional strategies to boost immunity and prevent infection in elderly individuals

1 reference

12 December 2020

Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections

1 reference

12 December 2020

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

1 reference

12 December 2020

Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections

1 reference

12 December 2020

Pharmacodynamics of fluoroquinolones.

1 reference

12 December 2020

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

1 reference

12 December 2020

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

1 reference

12 December 2020

Resistance surveillance in Italy: four-year results from the MYSTIC program

1 reference

12 December 2020

Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of the new fluoroquinolones: focus on respiratory infections

1 reference

12 December 2020

Antimicrobial therapy for the elderly patient

1 reference

12 December 2020

An Outbreak of Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides in a French General Hospital

1 reference

12 December 2020

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

1 reference

12 December 2020

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

1 reference

12 December 2020

Changes in vancomycin pharmacokinetics during treatment

1 reference

12 December 2020

Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient—importance of low-level resistance to vancomycin

1 reference

12 December 2020

Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy

1 reference

12 December 2020

Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).

1 reference

12 December 2020

Ototoxicity induced by once-daily gentamicin.

1 reference

12 December 2020

Fluoroquinolones in the elderly: safety considerations

1 reference

12 December 2020

Vancomycin resistance in staphylococci

1 reference

12 December 2020

Review of macrolides and ketolides: focus on respiratory tract infections

1 reference

12 December 2020

The problem with cephalosporins

1 reference

12 December 2020

Clinical relevance of penicillin-resistant Streptococcus pneumoniae

1 reference

12 December 2020

1 reference

12 December 2020

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

12 December 2020

Antibiotic efflux mechanisms.

1 reference

12 December 2020

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

1 reference

12 December 2020

Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections

1 reference

12 December 2020

The new oral cephalosporins in community-acquired infections

1 reference

12 December 2020

Community-acquired pneumonia in the elderly. Clinical and nutritional aspects

1 reference

12 December 2020

Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. The British Thoracic Society

1 reference

12 December 2020

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

1 reference

12 December 2020

Staphylococcus aureus infections and antibiotic resistance in older adults

1 reference

12 December 2020

Quinupristin/dalfopristin: a therapeutic review

1 reference

12 December 2020

Community-acquired pneumonia in elderly patients

1 reference

12 December 2020

Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa

1 reference

12 December 2020

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

1 reference

12 December 2020

Acute exacerbations of chronic bronchitis: an international comparison

1 reference

12 December 2020

The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia

1 reference

12 December 2020

Microbiological profile of telithromycin, the first ketolide antimicrobial

1 reference

12 December 2020

Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae

1 reference

12 December 2020

The pharmacologic and bacteriologic properties of oxazolidinones, a new class of synthetic antimicrobials.

1 reference

12 December 2020

The pharmacokinetics of cefuroxime in the elderly

1 reference

12 December 2020

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

1 reference

12 December 2020

Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival

1 reference

12 December 2020

Rational approach to the antibiotic treatment of pneumonia in the elderly

1 reference

12 December 2020

High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands

1 reference

12 December 2020

Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study

1 reference

12 December 2020

The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project

1 reference

12 December 2020

Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy

1 reference

12 December 2020

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of levofloxacin

1 reference

12 December 2020

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections

1 reference

12 December 2020

Levofloxacin failure in a patient with pneumococcal pneumonia

1 reference

12 December 2020

Antimicrobial therapy in the elderly

1 reference

12 December 2020

Streptococcus pneumoniae respiratory tract infections

1 reference

12 December 2020

ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society

1 reference

12 December 2020

Community-acquired pneumonia in the elderly

1 reference

12 December 2020

Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study

1 reference

12 December 2020

Appropriate use of antibiotics for respiratory infections: review of recent statements and position papers

1 reference

12 December 2020

Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.

1 reference

12 December 2020

Pneumococcal vaccination: current and future issues

1 reference

12 December 2020

Streptococcus pneumoniae resistance to fluoroquinolones

1 reference

12 December 2020

Risk factors for nosocomial pneumonia in a geriatric hospital: a control-case one-center study.

1 reference

12 December 2020

Acute confusion in elderly medical patients

1 reference

12 December 2020

Therapy of ventilator-associated pneumonia. A patient-based approach based on the ten rules of "The Tarragona Strategy".

1 reference

12 December 2020

Age and sex effects on the pharmacokinetics of linezolid

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of newer macrolides

1 reference

12 December 2020

Determination of antibody responses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination

1 reference

12 December 2020

Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin

1 reference

12 December 2020

Community-acquired pneumonia in Europe: causative pathogens and resistance patterns.

1 reference

12 December 2020

Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci

1 reference

12 December 2020

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

1 reference

12 December 2020

Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).

1 reference

12 December 2020

Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance

1 reference

12 December 2020

Hospital-acquired pneumonia: challenges and options for diagnosis and treatment

1 reference

12 December 2020

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy

1 reference

12 December 2020

10.2165/00002512-200421030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1035591101

0 references

1 reference